I own Pro Medicus Ltd (ASX: PME) shares, Resmed CDI (ASX: RMD) shares and Telix Pharmaceuticals Ltd (ASX: TLX) shares. This article explains why I own PME, RMD and TLX.
The S&P/ASX 200 (ASX: XJO) fell on Thursday, following a global lead that was driven by the selloff of technology and semiconductor names like NVIDIA (NASDAQ: NVDA).
The Telix Pharmaceuticals Ltd (ASX:TLX) share price has surged more than 12% in response to positive news in the US.
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is down after shelving its plans to list in the United States.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.13% to 7,049.40.
The wall of worry continues to pressure the Australian share market with the escalating conflict sending both the S&P/ASX200 (INDEXASX: XJO) and All Ordinaries (INDEXASX: XAO) more than 1% on Thursday.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.36% to 6981.60.
Damian Cottier dives into why and how ASX investors can use ESG principles to their advantage, and offers up three examples in Telix Pharmaceuticals (ASX: TLX), Alpha HPA Ltd (ASX: A4n) and Calix Ltd (ASX: CXL).
Owen Rask and Drew Meredith are back on The Australian Investors Podcast for 2 Sense. This week, Drew and Owen talk crypto, getting financial advice, SMSFs, IVV’s stock split and JP Morgan Asset Management’s 10 year macro outlook. And of course, we answer your questions.
